About Actimis
Actimis is a company based in San Diego (United States) founded in 2004 was acquired by Boehringer Ingelheim in June 2008. Actimis has raised $15.6 million across 2 funding rounds from investors including Boehringer Ingelheim, Sanderling Ventures and Mitsui Ventures.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$15.6 M (USD)
in 2 rounds
-
Latest Funding Round
$9.6 M (USD), Series B
Jun 06, 2008
-
Investors
Boehringer Ingelheim
& 2 more
-
Employee Count
Not available
-
Acquired by
Boehringer Ingelheim
(Jun 17, 2008)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Actimis
Actimis has successfully raised a total of $15.6M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $9.6 million completed in June 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Actimis
Actimis has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Boehringer Ingelheim, Sanderling Ventures and Mitsui Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biomedical investment financing and active management services.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Generic drugs and clinical research services are provided globally.
|
Locked | Locked | Locked |
Investor details for Actimis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Actimis
Investment portfolio details for Actimis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Actimis
Detailed financials for Actimis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Actimis Comparisons
Peer comparison for Actimis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Actimis
Detailed competitors of Actimis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Actimis
Complete news archive for Actimis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Actimis
Actimis was founded in 2004 and raised its 1st funding round 1 year after it was founded.
Actimis is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Actimis is a funded company, having raised a total of $15.6M across 2 funding rounds to date.
Actimis Pharmaceuticals is a privately held biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for severe respiratory, inflammatory and autoimmune diseases such as asthma, chronic obstructive pulmonary disease, inflammatory dermatoses, inflammatory bowel disease and rheumatoid arthritis. Actimis was spun off from Bayer Healthcare AG in November 2004. It got acquired by Boehringer-Ingelheim in 2008.
Actimis has 3 investors. Key investors include Boehringer Ingelheim, Sanderling Ventures, and Mitsui Ventures.